May
29
Blog
Recent Posts
- JHL Biotech Announces Completion of Convertible Bond Issuance and Appointment of New Chief Financial Officer
- China: Sequoia-backed biopharma startup JHL Biotech raises $106m
- JHL Biotech’s Clinical Trial Application Accepted by China for Bevacizumab Biosimilar to Treat Colorectal, Lung, and Ovarian Cancers
Comments are closed.